April 01, 2026

FDA Broadens CFTR Therapy Eligibility

The FDA expanded use of CFTR modulators to include more CF gene variants, increasing treatment eligibility across a wider US patient population.

Conexiant

March 31, 2026

FDA Monthly Preview: Key April Decisions to Watch

Several high-stakes FDA decisions across multiple specialties are expected this month.

Conexiant

March 30, 2026

Top 10 States With the Most Favorable Tax Climate for Physicians

These 10 states differ in how they structure income, property, and sales taxes—factors that can influence overall tax exposure for physicians.

Conexiant

March 27, 2026

Mental Health Content Accuracy Varies

Researchers found misinformation rates ranged from 0% to 57% across platforms and topics, with higher rates reported in several TikTok studies compared with YouTube.

Conexiant

March 27, 2026

FDA Drops Age Limit for Neffy

Needle-free epinephrine expands access for younger children meeting weight criteria

Conexiant

March 26, 2026

St. Louis Pediatrician Gets 20-Year Sentence

A physician exploited patients with addiction for nearly a decade, trading prescriptions for sex acts, photos, and cash

Conexiant

March 23, 2026

Lyme Vaccine Advances in Late Trial

Large global study evaluates novel prevention strategy.

Conexiant

March 23, 2026

Top 10 States for Retiring Physicians: Where Part-Time Practice, Licensing Flexibility, and Lifestyle Align

These 10 states make it easier for physicians to scale back, stay licensed, and enjoy retirement on their own terms.

Conexiant

March 18, 2026

FDA Approves New Oral Option for Plaque Psoriasis

Phase 3 data showed high skin clearance rates and adverse event rates similar to placebo through week 16 with once-daily icotrokinra.

Conexiant

March 18, 2026

AAP, NASPGHAN Issue Guidance on Faltering Weight in Children

New recommendations standardize diagnosis and aim to reduce unnecessary interventions in early childhood growth concerns.

Conexiant